ƽÌØÎå²»ÖÐ

Event

Neurogenesis: New Faculty Recruit Speaker Series

Thursday, December 15, 2022 16:00to17:00
Sherbrooke 1010 Suite 1800, Lovelace Conference Room, 1010 rue Sherbrooke Ouest, Montréal, H3A 2R7, CA

event header for Dec. 15, 2022, Neurogenesis seminar featuring Yang Zhou and JF Poulin

Neurogenesis: HBHL's New Faculty Recruit Speaker Series

Thursday, December 15, 2022
4:00–5:00 p.m. (with post-event 5 à 7)

1010 Sherbrooke St. West, Suite 1800

°Õ³ó±ðÌýNeurogenesis speakerÌýseries will give you the opportunity to get to know HBHL’s new recruits firsthand—to learn about their research, ask questions and get to know them over drinks.

Each event in the series will feature two HBHL faculty recruits whose research areas provide an interesting contrast or intersection for discussion.

December speakers:

  • Yang Zhou, PhD—A role of chromatin remodeling factor in glial cells
  • Jean-Francois Poulin, PhD—Dopamine neuron diversity in brain health and diseases

Ìý

Registration for this event is now full. Stay tuned for the next seminar in the series. Thanks for your interest in Neurogenesis!

Ìý


Speakers

Yang Zhou

Headshot portrait of Dr. Yang ZhouYang Zhou's lab is developing and applying technologies to engineer genetic mutations associated with neurological disorders in order to better understand how these mutations impact the neural circuits and behavior in model organisms. This research will identify causes of disease and allow the testing of genetic-based therapeutic approaches, as well as investigations into how genetic disturbances of neural circuits influence learning and cognition.


Ìý

Jean-Francois Poulin

Headshot portrait of Dr. Yang ZhouJ.F. Poulin's lab has developed novel transgenic approaches to demonstrate that different subtypes of dopamine neurons display distinct axonal projections and has also shown that one particular subtype is more vulnerable to Parkinson’s disease. These findings strongly suggest that each subtype is potentially associated with a specific circuit, function and/or disease. The lab's future research aims to investigate how dopamine circuits are altered in transgenic mouse models of neurodevelopmental and neurodegenerative disorders.

Ìý

Ìý

Back to top